img

Global Senolytic Drug Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Senolytic Drug Market Research Report 2024

According to MRAResearch’s new survey, global Senolytic Drug market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Senolytic Drug market research.
Key companies engaged in the Senolytic Drug industry include AgeX Therapeutics, Inc., Cleara Biotech, Eternans Ltd., FoxBio Inc, Numeric Biotech, T.A. Sciences, Inc. and Recursion Pharmaceuticals, Inc., etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Senolytic Drug were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Senolytic Drug market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Senolytic Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


AgeX Therapeutics, Inc.
Cleara Biotech
Eternans Ltd.
FoxBio Inc
Numeric Biotech
T.A. Sciences, Inc.
Recursion Pharmaceuticals, Inc.
Segment by Type
FOXO4-related Peptides
Bcl-2 Family Inhibitors
Navitoclax
Dasatinib and Quercetin
Others

Segment by Application


Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Senolytic Drug report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Senolytic Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 FOXO4-related Peptides
1.2.3 Bcl-2 Family Inhibitors
1.2.4 Navitoclax
1.2.5 Dasatinib and Quercetin
1.2.6 Others
1.3 Market by Application
1.3.1 Global Senolytic Drug Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Retail Pharmacies
1.3.3 Hospital Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Senolytic Drug Market Perspective (2018-2033)
2.2 Senolytic Drug Growth Trends by Region
2.2.1 Global Senolytic Drug Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Senolytic Drug Historic Market Size by Region (2018-2023)
2.2.3 Senolytic Drug Forecasted Market Size by Region (2024-2033)
2.3 Senolytic Drug Market Dynamics
2.3.1 Senolytic Drug Industry Trends
2.3.2 Senolytic Drug Market Drivers
2.3.3 Senolytic Drug Market Challenges
2.3.4 Senolytic Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Senolytic Drug Players by Revenue
3.1.1 Global Top Senolytic Drug Players by Revenue (2018-2023)
3.1.2 Global Senolytic Drug Revenue Market Share by Players (2018-2023)
3.2 Global Senolytic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Senolytic Drug Revenue
3.4 Global Senolytic Drug Market Concentration Ratio
3.4.1 Global Senolytic Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Senolytic Drug Revenue in 2022
3.5 Senolytic Drug Key Players Head office and Area Served
3.6 Key Players Senolytic Drug Product Solution and Service
3.7 Date of Enter into Senolytic Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Senolytic Drug Breakdown Data by Type
4.1 Global Senolytic Drug Historic Market Size by Type (2018-2023)
4.2 Global Senolytic Drug Forecasted Market Size by Type (2024-2033)
5 Senolytic Drug Breakdown Data by Application
5.1 Global Senolytic Drug Historic Market Size by Application (2018-2023)
5.2 Global Senolytic Drug Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Senolytic Drug Market Size (2018-2033)
6.2 North America Senolytic Drug Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Senolytic Drug Market Size by Country (2018-2023)
6.4 North America Senolytic Drug Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Senolytic Drug Market Size (2018-2033)
7.2 Europe Senolytic Drug Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Senolytic Drug Market Size by Country (2018-2023)
7.4 Europe Senolytic Drug Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Senolytic Drug Market Size (2018-2033)
8.2 Asia-Pacific Senolytic Drug Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Senolytic Drug Market Size by Region (2018-2023)
8.4 Asia-Pacific Senolytic Drug Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Senolytic Drug Market Size (2018-2033)
9.2 Latin America Senolytic Drug Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Senolytic Drug Market Size by Country (2018-2023)
9.4 Latin America Senolytic Drug Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Senolytic Drug Market Size (2018-2033)
10.2 Middle East & Africa Senolytic Drug Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Senolytic Drug Market Size by Country (2018-2023)
10.4 Middle East & Africa Senolytic Drug Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AgeX Therapeutics, Inc.
11.1.1 AgeX Therapeutics, Inc. Company Detail
11.1.2 AgeX Therapeutics, Inc. Business Overview
11.1.3 AgeX Therapeutics, Inc. Senolytic Drug Introduction
11.1.4 AgeX Therapeutics, Inc. Revenue in Senolytic Drug Business (2018-2023)
11.1.5 AgeX Therapeutics, Inc. Recent Development
11.2 Cleara Biotech
11.2.1 Cleara Biotech Company Detail
11.2.2 Cleara Biotech Business Overview
11.2.3 Cleara Biotech Senolytic Drug Introduction
11.2.4 Cleara Biotech Revenue in Senolytic Drug Business (2018-2023)
11.2.5 Cleara Biotech Recent Development
11.3 Eternans Ltd.
11.3.1 Eternans Ltd. Company Detail
11.3.2 Eternans Ltd. Business Overview
11.3.3 Eternans Ltd. Senolytic Drug Introduction
11.3.4 Eternans Ltd. Revenue in Senolytic Drug Business (2018-2023)
11.3.5 Eternans Ltd. Recent Development
11.4 FoxBio Inc
11.4.1 FoxBio Inc Company Detail
11.4.2 FoxBio Inc Business Overview
11.4.3 FoxBio Inc Senolytic Drug Introduction
11.4.4 FoxBio Inc Revenue in Senolytic Drug Business (2018-2023)
11.4.5 FoxBio Inc Recent Development
11.5 Numeric Biotech
11.5.1 Numeric Biotech Company Detail
11.5.2 Numeric Biotech Business Overview
11.5.3 Numeric Biotech Senolytic Drug Introduction
11.5.4 Numeric Biotech Revenue in Senolytic Drug Business (2018-2023)
11.5.5 Numeric Biotech Recent Development
11.6 T.A. Sciences, Inc.
11.6.1 T.A. Sciences, Inc. Company Detail
11.6.2 T.A. Sciences, Inc. Business Overview
11.6.3 T.A. Sciences, Inc. Senolytic Drug Introduction
11.6.4 T.A. Sciences, Inc. Revenue in Senolytic Drug Business (2018-2023)
11.6.5 T.A. Sciences, Inc. Recent Development
11.7 Recursion Pharmaceuticals, Inc.
11.7.1 Recursion Pharmaceuticals, Inc. Company Detail
11.7.2 Recursion Pharmaceuticals, Inc. Business Overview
11.7.3 Recursion Pharmaceuticals, Inc. Senolytic Drug Introduction
11.7.4 Recursion Pharmaceuticals, Inc. Revenue in Senolytic Drug Business (2018-2023)
11.7.5 Recursion Pharmaceuticals, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Senolytic Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of FOXO4-related Peptides
Table 3. Key Players of Bcl-2 Family Inhibitors
Table 4. Key Players of Navitoclax
Table 5. Key Players of Dasatinib and Quercetin
Table 6. Key Players of Others
Table 7. Global Senolytic Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Senolytic Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Senolytic Drug Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Senolytic Drug Market Share by Region (2018-2023)
Table 11. Global Senolytic Drug Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Senolytic Drug Market Share by Region (2024-2033)
Table 13. Senolytic Drug Market Trends
Table 14. Senolytic Drug Market Drivers
Table 15. Senolytic Drug Market Challenges
Table 16. Senolytic Drug Market Restraints
Table 17. Global Senolytic Drug Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Senolytic Drug Market Share by Players (2018-2023)
Table 19. Global Top Senolytic Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Senolytic Drug as of 2022)
Table 20. Ranking of Global Top Senolytic Drug Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Senolytic Drug Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Senolytic Drug Product Solution and Service
Table 24. Date of Enter into Senolytic Drug Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Senolytic Drug Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Senolytic Drug Revenue Market Share by Type (2018-2023)
Table 28. Global Senolytic Drug Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Senolytic Drug Revenue Market Share by Type (2024-2033)
Table 30. Global Senolytic Drug Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Senolytic Drug Revenue Market Share by Application (2018-2023)
Table 32. Global Senolytic Drug Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Senolytic Drug Revenue Market Share by Application (2024-2033)
Table 34. North America Senolytic Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. North America Senolytic Drug Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Senolytic Drug Market Size by Country (2024-2033) & (US$ Million)
Table 37. Europe Senolytic Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. Europe Senolytic Drug Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Senolytic Drug Market Size by Country (2024-2033) & (US$ Million)
Table 40. Asia-Pacific Senolytic Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 41. Asia-Pacific Senolytic Drug Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Senolytic Drug Market Size by Region (2024-2033) & (US$ Million)
Table 43. Latin America Senolytic Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Latin America Senolytic Drug Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Senolytic Drug Market Size by Country (2024-2033) & (US$ Million)
Table 46. Middle East & Africa Senolytic Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Middle East & Africa Senolytic Drug Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Senolytic Drug Market Size by Country (2024-2033) & (US$ Million)
Table 49. AgeX Therapeutics, Inc. Company Detail
Table 50. AgeX Therapeutics, Inc. Business Overview
Table 51. AgeX Therapeutics, Inc. Senolytic Drug Product
Table 52. AgeX Therapeutics, Inc. Revenue in Senolytic Drug Business (2018-2023) & (US$ Million)
Table 53. AgeX Therapeutics, Inc. Recent Development
Table 54. Cleara Biotech Company Detail
Table 55. Cleara Biotech Business Overview
Table 56. Cleara Biotech Senolytic Drug Product
Table 57. Cleara Biotech Revenue in Senolytic Drug Business (2018-2023) & (US$ Million)
Table 58. Cleara Biotech Recent Development
Table 59. Eternans Ltd. Company Detail
Table 60. Eternans Ltd. Business Overview
Table 61. Eternans Ltd. Senolytic Drug Product
Table 62. Eternans Ltd. Revenue in Senolytic Drug Business (2018-2023) & (US$ Million)
Table 63. Eternans Ltd. Recent Development
Table 64. FoxBio Inc Company Detail
Table 65. FoxBio Inc Business Overview
Table 66. FoxBio Inc Senolytic Drug Product
Table 67. FoxBio Inc Revenue in Senolytic Drug Business (2018-2023) & (US$ Million)
Table 68. FoxBio Inc Recent Development
Table 69. Numeric Biotech Company Detail
Table 70. Numeric Biotech Business Overview
Table 71. Numeric Biotech Senolytic Drug Product
Table 72. Numeric Biotech Revenue in Senolytic Drug Business (2018-2023) & (US$ Million)
Table 73. Numeric Biotech Recent Development
Table 74. T.A. Sciences, Inc. Company Detail
Table 75. T.A. Sciences, Inc. Business Overview
Table 76. T.A. Sciences, Inc. Senolytic Drug Product
Table 77. T.A. Sciences, Inc. Revenue in Senolytic Drug Business (2018-2023) & (US$ Million)
Table 78. T.A. Sciences, Inc. Recent Development
Table 79. Recursion Pharmaceuticals, Inc. Company Detail
Table 80. Recursion Pharmaceuticals, Inc. Business Overview
Table 81. Recursion Pharmaceuticals, Inc. Senolytic Drug Product
Table 82. Recursion Pharmaceuticals, Inc. Revenue in Senolytic Drug Business (2018-2023) & (US$ Million)
Table 83. Recursion Pharmaceuticals, Inc. Recent Development
Table 84. Research Programs/Design for This Report
Table 85. Key Data Information from Secondary Sources
Table 86. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Senolytic Drug Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Senolytic Drug Market Share by Type: 2022 VS 2033
Figure 3. FOXO4-related Peptides Features
Figure 4. Bcl-2 Family Inhibitors Features
Figure 5. Navitoclax Features
Figure 6. Dasatinib and Quercetin Features
Figure 7. Others Features
Figure 8. Global Senolytic Drug Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 9. Global Senolytic Drug Market Share by Application: 2022 VS 2033
Figure 10. Retail Pharmacies Case Studies
Figure 11. Hospital Pharmacies Case Studies
Figure 12. Online Pharmacies Case Studies
Figure 13. Senolytic Drug Report Years Considered
Figure 14. Global Senolytic Drug Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global Senolytic Drug Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global Senolytic Drug Market Share by Region: 2022 VS 2033
Figure 17. Global Senolytic Drug Market Share by Players in 2022
Figure 18. Global Top Senolytic Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Senolytic Drug as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Senolytic Drug Revenue in 2022
Figure 20. North America Senolytic Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America Senolytic Drug Market Share by Country (2018-2033)
Figure 22. United States Senolytic Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Senolytic Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Senolytic Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Senolytic Drug Market Share by Country (2018-2033)
Figure 26. Germany Senolytic Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France Senolytic Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. Senolytic Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy Senolytic Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia Senolytic Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries Senolytic Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Senolytic Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Senolytic Drug Market Share by Region (2018-2033)
Figure 34. China Senolytic Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Japan Senolytic Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. South Korea Senolytic Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Southeast Asia Senolytic Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. India Senolytic Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Australia Senolytic Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Senolytic Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Senolytic Drug Market Share by Country (2018-2033)
Figure 42. Mexico Senolytic Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Brazil Senolytic Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Senolytic Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Senolytic Drug Market Share by Country (2018-2033)
Figure 46. Turkey Senolytic Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Saudi Arabia Senolytic Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. AgeX Therapeutics, Inc. Revenue Growth Rate in Senolytic Drug Business (2018-2023)
Figure 49. Cleara Biotech Revenue Growth Rate in Senolytic Drug Business (2018-2023)
Figure 50. Eternans Ltd. Revenue Growth Rate in Senolytic Drug Business (2018-2023)
Figure 51. FoxBio Inc Revenue Growth Rate in Senolytic Drug Business (2018-2023)
Figure 52. Numeric Biotech Revenue Growth Rate in Senolytic Drug Business (2018-2023)
Figure 53. T.A. Sciences, Inc. Revenue Growth Rate in Senolytic Drug Business (2018-2023)
Figure 54. Recursion Pharmaceuticals, Inc. Revenue Growth Rate in Senolytic Drug Business (2018-2023)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed